Lido Workset Study
Assessment of Spasticity in MS Patients Using a Lido Workset
Visão geral do estudo
Descrição detalhada
The information gathered from testing individuals with spasticity due to multiple sclerosis with the Lido Workset has been important in making adjustments to the Lido Workset to show a greater degree of sensitivity in assessing varying degrees of spasticity.
Healthy control subjects will be used to compare the spasticity data of multiple sclerosis subjects with subjects with normal muscle tone to determine the sensitivity of the Lido measurements.
The testing will be performed one time for each patient and will take approximately 25 minutes. The servo-controlled torque motor system will analyze resistance to passive movement of the knee. This testing may be repeated for a group of randomly selected subjects from both the MS subjects and control subjects. The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session. The total length of time for participation in this study may be up to three weeks. This additional testing will be done in order to compare the results with the Lido data obtained at similar timepoints from the subjects enrolled in the Cannabis for Spasticity in MS study. Each subject will be given the option to participate in the extended testing or to decline.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
California
-
Sacramento, California, Estados Unidos, 95817
- University of California, Davis
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Must have a diagnosis of multiple sclerosis and
- Must have some degree of spasticity or
- Must be a healthy control subject
- Ability to give informed consent
Exclusion Criteria:
- Patients with any life-threatening or unstable clinically significant disease
- Patients with other causes of reduced range of motion of the knee or wrist
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Arm I
50 subjects with multiple sclerosis will be tested one time on the Lido Workset.
The test will take approximately 25 minutes.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
This testing may be repeated for a group of randomly selected subjects.
Each subject will be given the option to participate in the extended testing or to decline.
The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session.
The total length of time for participation in this study may be up to three weeks.
|
The intervention will consist of spasticity testing on the Lido Workset device.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
|
|
Arm II
25 normal subjects will be tested on the Lido workset.
The testing will be performed one time for each patient and will take approximately 25 minutes.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
This testing may be repeated for a group of randomly selected control subjects.
Each subject will be given the option to participate in the extended testing or to decline.
The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session.
The total length of time for participation in this study may be up to three weeks.
|
The intervention will consist of spasticity testing on the Lido Workset device.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Assess measure of spasticity
Prazo: 3 weeks
|
3 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Mark Agius, MD, University of California, Davis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 200310977
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .